Skip Navigation

A Phase I/II study of Bosutinib in pediatric patients with newly diagnosed chronic phase or resistant/intolerant Ph+ Chronic Myeloid Leukemia

Brief Summary


Study Type:

I/II Identifier:

Study #:
CMH - AAML1921

Start Date:
Dec 01, 2020

Full Details and Eligibility at

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below. ID: NCT04258943

View Complete Trial Details & Eligibility at